Quốc gia: Canada
Ngôn ngữ: Tiếng Anh
Nguồn: Health Canada
TERBINAFINE (TERBINAFINE HYDROCHLORIDE)
AURO PHARMA INC
D01BA02
TERBINAFINE
250MG
TABLET
TERBINAFINE (TERBINAFINE HYDROCHLORIDE) 250MG
ORAL
28/100
Prescription
ALLYLAMINES
Active ingredient group (AIG) number: 0132855002; AHFS:
APPROVED
2008-12-03
PRODUCT MONOGRAPH PR AURO-TERBINAFINE (Terbinafine Tablets) 250 mg terbinafine (as terbinafine hydrochloride) ANTIFUNGAL AGENT AURO PHARMA INC. Date of Revision: 3700 Steeles Avenue West, Suite # 402, July 27, 2016 Woodbridge, Ontario, L4L8K8 CANADA Submission Control No.: 196718 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ………………………… 3 SUMMARY PRODUCT INFORMATION ……………………………………… 3 INDICATIONS AND CLINICAL USE …………………………………………… 3 CONTRAINDICATIONS………………………….………………………….….. 4 WARNINGS AND PRECAUTIONS ……………………………...……………… 4 ADVERSE REACTIONS ………………………………………………….……… 8 DRUG INTERACTIONS …………………………………………….…………… 11 DOSAGE AND ADMINISTRATION……………………….………… 14 OVERDOSAGE ………………………………………………………………….… 14 ACTION AND CLINICAL PHARMACOLOGY ……………………….………… 15 STORAGE AND STABILITY ……………………………………………………. 16 DOSAGE FORMS, COMPOSITION AND PACKAGING ……………………… 16 PART II: SCIENTIFIC INFORMATION …………………………………………. 17 PHARMACEUTICAL INFORMATION ………………………………………… 17 DETAILED PHARMACOLOGY ………………………………………………… 24 TOXICOLOGY …………………………………………….………………….…… 27 REFERENCES …………………………………………….…………………..…… 35 PART III: CONSUMER INFORMATION ……………………………………..… 40 PR AURO-TERBINAFINE (Terbinafine Tablets) 250 mg terbinafine (as terbinafine hydrochloride) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION ROUTE OF ADMINISTRATION DOSAGE FORM / STRENGTH ALL NON-MEDICINAL INGREDIENTS Oral Tablets 250 Đọc toàn bộ tài liệu